首页> 外文期刊>Urology >Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.
【24h】

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

机译:上尿路移行细胞癌的预后因素,复发率和生存率:252例患者已有30年的经验。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To review a large single-center experience of patients treated for upper tract transitional cell carcinoma (TCC) with extended follow-up in order to identify patterns of recurrence, assess patient outcomes, and determine the impact of traditional prognostic factors. METHODS: We reviewed 252 patients treated surgically for upper tract TCC with a median follow-up of 64 months. Most patients (77%) underwent nephroureterectomy, whereas 17% were treated with a parenchymal sparing approach. Traditional prognostic factors including age, sex, tumor stage, grade, location, and type of surgical treatment were analyzed with respect to disease recurrence and survival. RESULTS: Disease relapse occurred in 67 patients (27%) at a median time of 12.0 months. Recurrences were local in the retroperitoneum (9%), the bladder (51%), remaining upper tract (18%), or distant in the lung, bone, or liver (22%). The 6 patients with local relapse were among the 73 patients with pT3 or pT4 tumors, and all died of TCC at a median time from diagnosis of 37 months. Significant prognostic factors for recurrence by univariate analysis were tumor grade (P = 0.0014) and stage (P = 0.0001). On multivariate analysis, only tumor stage (P = 0.017) and treatment modality (P = 0.020) were predictors of recurrence. Actuarial 5-year disease-specific survival rates by primary tumor stage were 100% for Ta/cis, 91.7% for T1, 72.6% for T2, and 40.5% for T3. Patients with primary Stage T4 tumors had a median survival of 6 months. Although tumor stage and grade correlated with disease-specific survival on univariate analysis, only patient age (P = 0.042) and stage (P = 0.0001) were significant on multivariate analysis with the type of surgical procedure performed approaching significance (P = 0.0504). CONCLUSIONS: Primary tumor stage and surgical procedure performed (radical versus parenchymal sparing) are important predictors of disease recurrence. Patient age and tumor stage were the only predictors of disease-specific survival on multivariate analysis with the type of surgical procedure approaching significance. Radical nephroureterectomy achieves excellent local control even in the setting of locally advanced (pT3 or T4) disease. The major clinical feature in this setting is distant failure, and the development of effective systemic therapy is needed to improve the outcome in these patients.
机译:目的:回顾长期随访的上道移行细胞癌(TCC)患者的单中心经验,以识别复发模式,评估患者预后并确定传统预后因素的影响。方法:我们回顾了252例接受手术治疗的上道TCC患者,中位随访时间为64个月。大多数患者(77%)接受了肾结直肠切除术,而17%的患者采用了实质性保留疗法。就疾病的复发和存活情况,分析了传统的预后因素,包括年龄,性别,肿瘤分期,等级,位置和手术治疗的类型。结果:67名患者(27%)发生疾病复发,中位时间为12.0个月。复发在腹膜后局部(9%),膀胱(51%),剩余的上尿路(18%)或在肺,骨骼或肝脏远处复发(22%)。在73例患有pT3或pT4肿瘤的患者中,这6例局部复发患者均在诊断后37个月的中位时间死于TCC。单因素分析显示复发的重要预后因素是肿瘤分级(P = 0.0014)和分期(P = 0.0001)。在多变量分析中,只有肿瘤分期(P = 0.017)和治疗方式(P = 0.020)是复发的预测因子。按原发肿瘤分期的精算5年疾病特异性生存率Ta / cis为100%,T1为91.7%,T2为72.6%,T3为40.5%。原发性T4期肿瘤患者的中位生存期为6个月。尽管在单因素分析中肿瘤的分期和等级与疾病特异性生存率相关,但在多因素分析中,只有患者年龄(P = 0.042)和分期(P = 0.0001)显着,而所进行的手术方法类型也具有显着意义(P = 0.0504)。结论:原发肿瘤分期和手术方式(根治与实质保留)是疾病复发的重要预测指标。在多变量分析中,患者年龄和肿瘤分期是疾病特异性生存的唯一预测因素,而手术方法的类型则具有重要意义。根治性肾切除术即使在局部晚期(pT3或T4)疾病中也能实现出色的局部控制。这种情况下的主要临床特征是远距离衰竭,因此需要开发有效的全身疗法来改善这些患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号